vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $21.2M, roughly 1.8× Autolus Therapeutics plc). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
AUTL vs CWBC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $38.3M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 40.0% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 11.6% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.3M | ||
| Q3 25 | $21.2M | $37.9M | ||
| Q2 25 | $20.9M | $35.7M | ||
| Q1 25 | $9.0M | $34.8M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | $0 | $31.3M | ||
| Q2 24 | $0 | $30.5M | ||
| Q1 24 | $10.1M | $20.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $10.9M | ||
| Q2 25 | $-47.9M | $7.8M | ||
| Q1 25 | $-70.2M | $8.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $3.4M | ||
| Q2 24 | $-58.3M | $-6.3M | ||
| Q1 24 | $-52.7M | $3.7M |
| Q4 25 | — | 40.0% | ||
| Q3 25 | -337.9% | 39.8% | ||
| Q2 25 | -292.6% | 30.2% | ||
| Q1 25 | -726.3% | 32.7% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | -25.9% | ||
| Q1 24 | -384.1% | 23.2% |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 28.7% | ||
| Q2 25 | -229.0% | 22.0% | ||
| Q1 25 | -781.1% | 23.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | -20.7% | ||
| Q1 24 | -522.1% | 17.8% |
| Q4 25 | — | $0.58 | ||
| Q3 25 | $-0.30 | $0.57 | ||
| Q2 25 | $-0.18 | $0.41 | ||
| Q1 25 | $-0.26 | $0.44 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | $-0.31 | $0.18 | ||
| Q2 24 | $-0.22 | $-0.33 | ||
| Q1 24 | $-0.24 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $119.0M |
| Total DebtLower is stronger | — | $69.5M |
| Stockholders' EquityBook value | $265.5M | $409.6M |
| Total Assets | $661.9M | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $119.0M | ||
| Q3 25 | $86.1M | $121.6M | ||
| Q2 25 | $123.8M | $134.4M | ||
| Q1 25 | $95.8M | $148.4M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | $657.1M | $149.0M | ||
| Q2 24 | $705.9M | $109.7M | ||
| Q1 24 | $758.5M | $61.0M |
| Q4 25 | — | $69.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $409.6M | ||
| Q3 25 | $265.5M | $397.6M | ||
| Q2 25 | $346.5M | $380.0M | ||
| Q1 25 | $371.1M | $372.2M | ||
| Q4 24 | — | $362.7M | ||
| Q3 24 | $477.0M | $363.5M | ||
| Q2 24 | $527.8M | $350.2M | ||
| Q1 24 | $582.0M | $211.7M |
| Q4 25 | — | $3.7B | ||
| Q3 25 | $661.9M | $3.6B | ||
| Q2 25 | $721.0M | $3.6B | ||
| Q1 25 | $746.3M | $3.6B | ||
| Q4 24 | — | $3.5B | ||
| Q3 24 | $827.5M | $3.5B | ||
| Q2 24 | $853.6M | $3.5B | ||
| Q1 24 | $901.4M | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $46.1M |
| Free Cash FlowOCF − Capex | $-72.3M | $43.6M |
| FCF MarginFCF / Revenue | -341.2% | 113.9% |
| Capex IntensityCapex / Revenue | 20.8% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $46.1M | ||
| Q3 25 | $-67.9M | $13.2M | ||
| Q2 25 | $-72.8M | $11.5M | ||
| Q1 25 | $-75.6M | $11.1M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | $-76.7M | $7.8M | ||
| Q2 24 | $-51.1M | $5.2M | ||
| Q1 24 | $-40.5M | $4.0M |
| Q4 25 | — | $43.6M | ||
| Q3 25 | $-72.3M | $12.8M | ||
| Q2 25 | $-80.1M | $10.6M | ||
| Q1 25 | $-83.8M | $10.8M | ||
| Q4 24 | — | $17.2M | ||
| Q3 24 | $-86.3M | $5.2M | ||
| Q2 24 | $-51.9M | $4.8M | ||
| Q1 24 | $-41.0M | $3.6M |
| Q4 25 | — | 113.9% | ||
| Q3 25 | -341.2% | 33.7% | ||
| Q2 25 | -382.6% | 29.6% | ||
| Q1 25 | -933.1% | 30.9% | ||
| Q4 24 | — | 50.0% | ||
| Q3 24 | — | 16.7% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | -406.8% | 17.3% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 20.8% | 1.1% | ||
| Q2 25 | 34.8% | 2.7% | ||
| Q1 25 | 91.8% | 0.9% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | 5.3% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
